Cellular Events Preceding Acetaminophen Cataractogenesis Studied by Confocal Fluorescence Microscopy

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 5, 2003, Pages 483-492

  Mathur, Priya ^a   Peshenko, Igor V ^a   Shichi, Hitoshi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ARTICLE; BIOTRANSFORMATION; CALCIUM HOMEOSTASIS; CATARACTOGENESIS; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; LENS EPITHELIUM; MOUSE; NONHUMAN; STRAIN DIFFERENCE;

ACETAMINOPHEN; ANIMALS; CALPAIN; CATARACT; GLYCOPROTEINS; LENS, CRYSTALLINE; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 0142182389     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803322473033     Document Type: Article

References (25)

1. Shichi, H., Gassterland, D.E., Jensen, N.M., and Nebert, D.W. The Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen. Science. 200:539-541, 1978.
2. Lubek, B.M., Avaria, M., Basu, P.K., and Wells, P.G. Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits. Fundam. Appl. Toxicol. 10:596-606, 1988.
3. Rathbun, W.B., Holleschau, A.M., Cohen, J.F., and Nagasawa, H.T. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME. Invest. Ophthalmol. Vis. Sci. 37:923-929, 1996.
4. Patten, C.J., Thomas, P.E., Guy, R.L., Lee, M., Gonzalez, F.J., Guengerich, F.P., and Yang, C.S. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6:511-518, 1993.
5. Raucy, J.L., Lasker, J.M., Lieber, C.S., and Black, M. Acetaminophen activation by human liver cytochrome P450 2E1 and P450 1A2. Arch. Biochem. Biophys. 271:270-283, 1989.
6. Thummel, K.E., Lee, C.A., Kunze, K.L., Nelson, S.D., and Slattery, J.T. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP 3A4. Biochem. Pharmacol. 45:1563-1569, 1993.
7. Bessems, J.G.M., and Vermeulen, N.P.E. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 31:55-138, 2001.
8. Shichi, H., Tanaka, M., Jensen, N.M., and Nebert, D.W. Genetic differences in cataract and other abnormalities induced by paracetamol and naphthalene. Pharmacology 20:229-241, 1980.
9. Zhao, C., and Shichi, H. Histological study on the possible mechanism of acetaminophen cataractogenesis in mouse eye. Exp. Mol. Pathol. 63:118-128, 1995.
10. Zhao, C., Xiong, Y., and Shichi, H. Acetaminophen cytotoxicity in mouse eye: mitochondria in anterior tissues are the primary target. J. Ocular Pharmacol. Therapeut. 13:269-274, 1997.
11. Qian, W., Amin, R.H., and Shichi, H. Cytotoxic metabolite of acetaminophen, N-acetyl-p-benzoquinone imine, produces cataract in DBA2 mice. J. Ocular Pharmacol. Therapeut. 15:537-545, 1999.
12. 2+ and calpain activation. Exp. Eye Res. 71:567-574, 2000.
13. Bantseev, V., Herbert, K.L., Trevithick, J.R., and Sivak, J.G. Mitochondria of rat lenses: distribution near and at the sutures. Curr. Eye Res. 19:506-516, 1999.
14. Saido, T., Sorimachi, H., and Suzuki, K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8:814-822, 1994.
15. Azuma, M., Fukiage, C., David, L.L., and Shearer, T.R. Activation of calpain in lens: a review and proposed mechanism. Exp. Eye Res. 64:529-538, 1997.
16. Reverter, D., Sorimachi, H., and Bode, W. The structure of calcium-free human m-calpain. Implications for calpain activation and function. Trends Cardiovasc. Med. 11:222-229, 2001.
17. Murray, M., and Reidy G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42:85-101, 1990.
18. Kwak, M.K., Kim, S.G., Kwak, J.Y., Novak, R.F., and Kim, N.D. Inhibition of cytochrome P450 2E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethyl-sulfide in rats. Biochem. Pharmacol. 47:531-539, 1994.
19. Mitchell, J.R., Jollow, D.J., Potter, W.Z., Gillette, J.R., and Brodie, B.B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Therapeut. 187:211-217, 973.
20. Zhao, C., and Shichi, H. Prevention of acetaminophen-induced cataract by a combination of dillyl disulfide and N-acetylcysteine. J. Ocular Pharmacol. Therapeut. 14:345-355, 1998.
21. Martynkina, L.P., Qian, W., and Shichi, H. Naphthoquinone cataract in mice: mitochondrial change and protection by superoxide dismutase. J. Ocular Pharmacol. Therapeut. 18:231-239, 2002.
22. Mathur, P., Gupta, S.K., Wegener, A.R., Breipohl, W., Ahrend, M.H., Sharma, Y.D., Gupta, Y.K., and Vajpayee, R.B. Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vivo. Curr. Eye Res. 21:926-933, 2000.
23. Tamada, Y., Fukiage, C., Mizutani, K., Yamaguchi, M., Nakamura, Y., Azuma, M., and Shearer, T.R. Calpain inhibitor, SJA 6017, reduces the rate of formation of selenite induced cataract in rats. Curr. Eye Res. 22:280-285, 2001.
24. Takeuchi, N., Ito, H., Namiki, K., and Kamei, A. Effect of calpain on hereditary cataractous rat, ICR/f. Biol. Pharm. Bull. 24:1246-1251, 2001.
25. Donkor, I.O. A survey of calpain inhibitors. Curr. Medicinal Chem. 7:1171-1188, 2000.